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Background: Osteosarcoma (OS) is the most common primary bone tumor, with a propensity to metastasize to
the lungs. Five-year survival for metastatic OS is below 30%, and has not improved for several decades despite the
introduction of multi-agent chemotherapy. Understanding OS cell migration to the lungs requires an evaluation of
the lung microenvironment. Here we utilized an in vitro lung cell and OS cell co-culture model to explore the
interactions between OS and lung cells, hypothesizing that lung cells would promote OS cell migration and
survival. The impact of a novel anti-OS chemotherapy on OS migration and survival in the lung microenvironment
was also examined.
Methods: Three human OS cell lines (SJSA-1, Saos-2, U-2) and two human lung cell lines (HULEC-5a, MRC-5) were
cultured according to American Type Culture Collection recommendations. Human lung cell lines were cultured in
growth medium for 72 h to create conditioned media. OS proliferation was evaluated in lung co-culture and
conditioned media microenvironment, with a murine fibroblast cell line (NIH-3 T3) in fresh growth medium as
controls. Migration and invasion were measured using a real-time cell analysis system. Real-time PCR was utilized to
probe for Aldehyde Dehydrogenase (ALDH1) expression. Osteosarcoma cells were also transduced with a lentivirus
encoding for GFP to permit morphologic analysis with fluorescence microscopy. The anti-OS efficacy of Disulfiram,
an ALDH-inhibitor previously shown to inhibit OS cell proliferation and metastasis in vitro, was evaluated in each
microenvironment.
Results: Lung-cell conditioned medium promoted osteosarcoma cell migration, with a significantly higher
attractive effect on all three osteosarcoma cell lines compared to basic growth medium, 10% serum containing
medium, and NIH-3 T3 conditioned medium (p <0.05). Lung cell conditioned medium induced cell morphologic
changes, as demonstrated with GFP-labeled cells. OS cells cultured in lung cell conditioned medium had increased
alkaline phosphatase staining.
Conclusions: Lung endothelial HULEC-5a cells are attractants for OS cell migration, proliferation, and survival. The
SJSA-1 osteosarcoma cell line demonstrated greater metastatic potential than Saos-2 and U-2 cells. ALDH appears
to be involved in the interaction between lung and OS cells, and ALP may be a valuable biomarker for monitoring
functional OS changes during metastasis.
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Osteosarcoma (OS) is the most common primary bone
tumor, with most new cases diagnosed in the first two
decades of life [1, 2]. OS has a high propensity for
metastasis, and over 90% of OS metastases are to the
lungs [3]. The 5‑year survival of patients with primary
OS is about 70%. However, the survival of metastatic OS
has been below 30% for several decades, despite the
introduction of multi-agent chemotherapy [4]. Much of
this stagnation relates to our continued lack of under-
standing of the mechanisms of how OS cells migrate to
the lungs, and what properties of the lung micro-
environment are ideal for OS development and prolifera-
tion. Understanding the metastatic milieu is important
to the development of novel strategies to inhibit OS
metastases, and may lead to improved treatment out-
comes for patients who already have metastatic OS.
It is believed that OS cells flourish in the lung micro-
environment because of its high degree of vascularization
and oxygenation. However, the pulmonary microenviron-
ment is not unique in these traits. Prior work suggests that
the specific interaction between OS and lung cells is the
major determinant of three general fates of metastatic
cells: proliferation, quiescence or apoptosis. However, our
ability to regulate the OS-microenvironment to direct
cells to anti- or pro-metastatic outcomes remains limited.
Here we describe an in vitro lung and OS cell co-culture
model to explore the interactions between these cell types.
We hypothesize that lung cells promote OS cell migration
and survival.
Methods
Cell lines and culture
Three human osteosarcoma (OS) cell lines, SJSA-1, Saos-
2, and U-2 OS were purchased from American Type
Culture Collection (ATCC) and cultured according to
ATCC’s recommendations. Two human lung cell lines,
HULEC-5a and MRC-5, were also purchased from ATCC
and cultured according to their recommendations.
OS cell migration and proliferation
HULEC-5a and MRC-5 lines were cultured in growth
medium for 72 h. The conditioned media (CM) was
collected and centrifuged at 2000 rpm for 5 min. Each
well of a 24-well plate received 600 μl CM. A total of
1x104 OS cells were re-suspended in 100 μl basic DMEM
(without supplements), and loaded into a Corning Trans-
well permeable support with a pore size of 8 μm, which
was then placed into each well of the dish. After 48 h, the
Transwell supports were removed and the migrated cells
were quantified. CM from the murine fibroblast cell line
NIH-3 T3 and fresh growth medium were utilized as con-
trols. Proliferation was measured by co-culturing cells for
72 h, then removing the Transwell support and changingthe media to standard growth medium. Cells were allowed
to proliferate for 10 days, then fixed and Giemsa stained.
Real-Time OS cell migration and invasion
HULEC-5a and MRC-5 CM were harvested as above.
Utilizing the xCelligence Real-Time Cell Analysis system
(Acea Biosciences, Inc., San Diego, CA) real-time cell
migration was measured using CIM-plates seeded with
2x104 OS cells in 100 μl of serum free media. Readings
were taken every 15 min for 100 cycles and cell index
was plotted at different time points. The Cell Index is
defined as (Rn-Rb)/15, where Rn is the cell-electrode
impedance of the well when it contains cells and Rb is
the background impedance of the well with the media
alone. OS cell invasion assays were created in a similar
manner, with 3% Corning Matrigel used to pre-coat the
upper chamber.
OS and lung direct co-culture
OS cells were stably transduced with a lentivirus encod-
ing for green fluorescent protein (GFP). A total of 2x104
OSGFP cells were seeded in a 24-well plate. These same
wells were seeded with either 2x104 HULEC-5a or
MRC-5 cells. After 72 h, cell morphology was visualized
by fluorescence microscope.
Alkaline phosphatase (ALP) staining
A co-culture of 2x104 OS cells and 2x104 HULEC-5a
was performed for 24, 48 and 72 h. Multiple time points
were included to determine if ALP expression was differ-
ent between each group at a given time. At each time
point, cells were fixed and stained for ALP expression
using SigmaFAST BCIP/NBT (Sigma-Aldrich Co LLC,
USA). Similar to the direct OS and lung cell co-culture,
OS cells were also cultured in CM from HULEC-5a for
72 h and stained for ALP.
Real-time PCR
SJSA-1 and Saos-2 cells (1x105 each) were cultured in
growth media or HULEC-5a CM for 48 h. Total RNA was
harvested using Ambion Trizol Reagent (ThermoFisher
Scientific, USA). RNA (1 μg) was utilized for cDNA using
Applied Biosystems High Capacity cDNA kit (Thermo-
Fisher Scientific, USA). A total of 8 ng of cDNA was used
as template and PCR was run on an Applied Biosystems
StepOne Real-Time PCR Thermocycler (ThermoFisher
Scientific, USA). ALDH1 primer sequence was forward:
5’-CCTGTCCTACTCACCGATTTG-3’ and reverse: 5’-
CCTCCTCAGTTGCAGGATTAAA-3’.
Disulfiram treatment
Disulfiram (Sigma-Aldrich Co LLC, USA) was dissolved
in DMSO and in working concentrations of 10, 50, 100,
200 and 500 nM in growth medium or HULEC-5a CM.
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were seeded in each well of a 24-well plate for 24 h. In the
co-culture group, 2x104 HULEC cells together with 2x104
SJSA-1 or Saos-2 cells were seeded in each well of a 24-
well plate for 24 h. This was followed by adding fresh
growth media containing disulfiram and culturing for
another 72 h. Cells were then fixed and stained for ALP.
5-Bromo-2’-deoxyuridine (BrdU) staining
A 10 mM stock solution of BrdU (Sigma-Aldrich Co
LLC, USA) was diluted 1:1000 in growth medium or
HULEC CM. SJSA-1 or Saos-2 cells (2x104) were seeded
in a 24-well plate for 24 h. Cell medium was changed to
BrdU-containing medium for another 4 h. A BrdU staining
kit was used for immunohistochemistry (ThermoFisher
Scientific, USA).
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end-labeling (TUNEL) assay
OS Cells were grown in 24-well plates at a seeding dens-
ity of 2x104cells-per-well in growth media or HULEC-
CM for 48 h. TUNEL assay was carried out using
ApoptTag Peroxidase In Situ Apoptosis Detection Kit
(EMD Millipore, Billerica, MA, USA).
Statistical analysis
Data was analyzed using Prism 7.0 (GraphPad, La Jolla,
CA, USA). Multi-group analysis was performed using ana-
lysis of variance with Tukey’s post-test for between-group
comparisons. Two-group analysis was performed using t-
tests for parametric data and the Mann-Whitney U test
for non-parametric distributions. In all cases, p <0.05 was
considered significant. Values were expressed as mean ±
standard deviation.
Results
Lung cell conditioned medium (CM) induces OS cells
migration
To evaluate if different types of lung cells are variably
attractive to different OS cell lines, we used three OS
cell lines: Saos-2, SJSA-1 and U-2 OS, and two lung cell
lines, HULEC-5a and MRC-5, to perform Transwell
experiments. After 48 h, HULEC-5a CM had a signifi-
cantly higher (p <0.05) attractive effect on all three OS
cell lines compared to basic growth medium, 10% serum
containing medium and NIH3T3 CM. Among these
three OS cell-lines, Saos-2 cell had the highest and SJS1-
1 the lowest migration in HULEC-5a CM (Fig. 1a).
MRC-5 CM was more attractive to all three OS cell lines
compared to basic medium and 10% serum containing
medium, but not to NIH3T3 CM (Fig. 1a). To further
evaluate the dynamic migration of these three OS cell
lines in HULEC-5a CM and MRC-5 CM, we repeated
the migration experiment using the xCelligence Real-Time Cell Analysis system. HULEC-5a CM had a sig-
nificantly higher attractive effect on all three OS cell
lines. Moreover, real-time migration data reveals that
SJSA-1 cell migration in HULEC-5a CM peaks at 5 h,
U-2 OS cell migration peaks at 15 h and Saos-2 migra-
tion peaks at 20 h (Fig. 1b). Migration peaks were
determined by assessing the point at which the slope of
the curve was greatest.
Lung cells further increase OS cells migration
To dissect the role of lung cells in the attraction of OS cell
migration, we investigated Saos-2 and SJSA-1 cells migra-
tion in HULEC-5a CM containing 1x104 or 5x104 HULEC
cells. We found that 1x104 and 5x104 HULEC-5a cells,
when in the bottom well, increased SJSA-1 cell migration
compared to HULEC-5a CM in the bottom well. Interest-
ingly, Saos-2 migration in 1x104 HULEC-5a cells is signifi-
cantly higher than in 5x104 HULEC-5a cells or CM
(Fig. 2a). SJSA-1 cell migration started earlier than Saos-2
in both HULEC-5a cells and CM (Fig. 2a). When evaluat-
ing SJSA-1 migration in MRC-5 cells and CM, we found
that 1x104 MRC-5 cells led to SJSA-1 cell migration,
whereas MRC-5 CM and 5x104 cells had lower migration
rates than 1X104 cells (Fig. 2b).
Lung cell CM stimulates OS cell morphology change and
invasion
We used a lentivirus encoding for GFP to label the Saos-2,
SJSA-1 and U-2 OS cell lines (Fig. 3a, column 1, 3, 5).
Bright field pictures were taken of the same area (Fig. 3a,
column 2, 4, 6). We used several parameters to assess
morphologic changes in OS cells in the OS and lung cell
co-culture. Gross morphologic difference is measured by a
systematic difference in two-dimensional projected area.
Our results showed that Saos-2 and SJSA-1 cells have a
significantly larger projected area when in co-culture with
HULEC-5a or MRC-5 cells compared to isolated Saos-2
and SJSA-1 culture alone (Fig. 3a, columns 1 and 3). U-2
OS cells demonstrated the opposite trend, and had a
significantly smaller projected area in co-culture with
HULEC-5a and MRC-5 cells compared to U-2 OS cells
alone (Fig. 3a, column 5). Cell shape assesses roundness vs
elongation. Similar to changes in projected area, Saos-2
and SJSA-1 cells showed greater elongation and less
roundness when in co-culture with HULEC-5a or MRC-5
cells compared to isolated Saos-2 and SJSA-1 culture
(Fig. 3a, columns 1 and 3). U-2 OS again displayed the
opposite trend, showing reduced elongation but more
roundness when in co-culture with HULEC-5a and SJSA-
1 cells compared to U-2 OS alone (Fig. 3a, column 5).
Considering the cytoskeletal morphologic changes
during the acquisition of OS invasive capacity [5–7], we
assessed OS invasion in 3% Matrigel to HULEC-5a CM
and MRC-5 CM, again with the xCELLigence Real-Time
Fig. 1 Osteosarcoma cell migration increased in lung cell conditioned medium (CM). a Osteosarcoma cells migration in HULEC-5a and MRC5 cell CM
using transwell co-culture, NIH3T3 cell CM and cell culture medium (containing 10% FBS) are used as control. 600 μl CM was loaded to bottom
chamber of 24-well plate and 2x104 SaOS2, SJSA-1 and U2OS cells in 100 μl serum free medium were added to the top insert of transwell. Top insert
containing OS cells was put back were cultured in CM for 48 h, followed by counting the number of migrated cells. b Osteosarcoma cells migration in
HULEC-5A and MRC5 cell CM using xCELLigence system
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invasion capacity in the presence of HULEC-5a CM. In
contrast, U-2 OS cell invasiveness was relatively lower,
and Saos-2 cell migration was completely blocked by
Matrigel (Fig. 3b).
Lung cells induce ALP expression in OS cell lines
Alkaline Phosphatase (ALP) has been long appreciated to
correlate with active bone metabolism, and high ALP
levels correlate with OS metastases [8–11]. In addition to
morphologic changes, the OS metastatic phenotype corre-
lates with alkaline phosphatase (ALP) staining in OS cells
that have also changed in the presence of HULEC-5a co-
culture. ALP-positive staining appeared after 24 –48 h in
Saos-2 and SJSA-1 co-culture with HULEC-5a, while ALP
expression in Saos-2 and SJSA-1 cells was undetectable at
24 h and slightly increased at 48 h (Fig. 4a, b, c). At 72 h,
ALP staining in Saos-2 and SJSA-1 in co-culture with
HULEC-5a was still significantly greater than from Saos-2
or SJSA-1 cells alone (Fig. 4a, b, c). ALP in U-2 OS and
HULEC-5a cells was undetectable at 24, 48 and 72 h
(Fig. 4a, b, c). To determine if HULEC-5a cells arerequired to increase ALP expression, we used HULEC-5a
CM in the co-culture and analyzed ALP expression in
Saos-2, SJSA-1 and U-2 OS. There was no significant
difference in ALP expression between regular medium
and CM (Fig. 4d, e, f ).
Lung cell supported migrated cell survival
The survival of migrating OS cells is a critical step in OS
metastasis. To explore the effects of lung cells on
migrated OS cell survival, we induced Saos-2, SJSA-1
and U-2 OS cell migration in HULEC-5a and MRC-5
CM for 72 h, then switched to regular culture medium
for an additional 10 days. Compared to migrated Saos-2
and SJSA-1 cells, migrated U-2 OS cells had the most
colony growth in regular medium, HULEC-5a CM and
MRC-5 CM. Migrated SJSA-1 cells grew in HULEC-5a
CM, but not MRC-5 CM. Migrated Saos-2 cells were
not observed in HULEC-5a CM, MRC-5 CM and con-
trol media (Fig. 5a, b). To uncover the mechanisms
underlying increased cell migration, we assessed mi-
grated OS cell proliferation and found that HULEC-5a
CM benefited SJSA-1 cell proliferation (Fig. 5c).
Fig. 2 Osteosarcoma cells migration to lung cell CM were further increased in the presence of lung cells that were placed in the bottom
chamber of the transwell. a 160 μl of HULEC-5a CM, HULEC-5a CM containing 1x104 HULEC cell, and HULEC-5a CM containing 5x104 HULEC cell
were loaded onto the bottom well of CIM Plate 16. 2x104 SaOS2 or SJSA-1 cells in 100 μl serum free medium were added to the top well of CIM
Plate 16. OS cell migration index was calculated every 15 min for 100 reading. Each plate had negative controls where no cells were added to
the top well and either serum free media or FBS was added to the bottom well. b 160 μl of HULEC-5a CM, HULEC-5a CM containing 1x104 HULEC
cell, and HULEC-5a CM containing 5x104 HULEC cell were placed in the bottom chamber of the transwell and compared to MRC5 CM, MRC5 CM
containing 1x104 MRC5 cell and MRC5 CM containing 5x104 MRC5 loaded onto the bottom well of CIM-Plate 16. 2x104 SJSA-1 cells in 100 μl
serum free medium were added to top well of CIM Plate 16, and SJSA-1 cell migration index was calculated every 15 min for 100 reading. Each
plate had negative controls where no cells were added to the top well and either serum free media or FBS was added to the bottom well. Serum
free media in the bottom well was also tested with SJSA cells
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interaction
Akdehyde dehydrogenase (ALDH) mRNA level in Saos-2
and SJSA-1 cells was elevated after being cultured in
HULEC-5a CM, at a fold change of 9 and 22, respectively
(Fig. 6a). To further investigate the role of this cancer
stem cell marker in the interaction between lung and OS
cells, we treated co-cultured cells with disulfiram, an
ALDH-specific inhibitor, at doses of 10, 50, 100, 200 and
500 nM for 72 h. We found that ALP staining of Saos-2
cells was significantly suppressed in a dose dependent
manner, in particular at a dose of 100 nM and higher.
Moreover, HULEC-5a cells reversed the disulfiram-
mediated suppression of ALP in Saos-2 cells at 100 nM,
but not at higher disulfiram doses of 200 and 500 nM
(Fig. 6b). HULEC-5a CM did not affect the disulfiram-
mediated suppression of ALP in Saos-2 cells (Fig. 6b).ALP expression of SJSA-1 was also significantly inhibited
by disulfiram in a dose-dependent manner. HULEC-5a
cells attenuated the suppression of ALP expression in
SJSA-1 cells even at higher doses of disulfiram (500nM).
The effect of HULEC-5a CM on the ALP expression of
SJSA-1 cells is similar to HULEC-5a cells (Fig. 6b). On the
contrary, MRC-5 cells did not influence the disulfiram-
mediated inhibition of ALP expression in Saos-2 and
SJSA-1 cells (Fig. 6b, d). Interestingly, HULEC-5a CM
increases Saos-2 and SJSA-1 cell proliferation in the
presence of 100 nM disulfiram for 48 h (Fig. 6c).
Discussion
OS is the most common primary malignant bone tumor,
with peak incidence rates during adolescence [12–14].
Pulmonary OS metastasis is the predominant determin-
ant of disease mortality [4]. However, the mechanisms
Fig. 3 Osteosarcoma cells morphology changed in the co-culture of HULEC-5a and MRC5 cell. a GFP-labeled SaOS2, SJSA-1 and U2OS cells were
co-cultured with HULEC-5a or MRC5 cells for 72 h. b Osteosarcoma cells invasion to in HULEC-5A and MRC5 cell CM using xCELLigence system.
Top wells of CIM-plate 16 were pre-coated by 3% Matrigel and incubated in 37 °C for 4 h, followed by performing the same procedure in cell
migration in Fig. 2
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interaction with lung cells remain poorly understood.
Here we found that different OS cell sub-types have
different capacities for migration in response to the same
human lung cell-line. The SJSA-1 cell-line, a so-called
fibroblastic OS cell-line with a high metastatic potential,
had significantly greater migration and metastasis
marker gene expression in response to HULEC-5a cell
exposure compared to Saos-2 and U-2 OS cells, two epi-
thelial OS cell-lines. Further, different types of lung cells
have different attractive potential. SJSA-1 migration and
invasion in the presence of HULEC-5a, a lung endothe-
lial cell-line, is significantly greater than in the presence
of MRC-5, a fibroblastic lung cell-line.
Heterogeneity of OS cell with different metastatic
potential has different response to lung cell environment:
cell or cell-conditioned medium
The SJSA-1 cell line has been used as an OS metastatic
model in several prior studies [15–19], and Saos-2 and
U-2 OS cells have been found to have an undetectable
metastatic effect [16, 19]. We therefore used SJSA-1 as
our pro-metastatic cell model, and Saos-2 and U-2 OSas controls. In line with previous reports, our data
demonstrated that SJSA-1 has a significantly higher
migration potential when exposed to HULEC-5a CM
compared to control medium (Figs. 1a, b, 2a, b, 5a and b).
Although Saos-2 cells have a slightly higher migration rate
than SJSA-1 cells (Fig. 1b), Saos-2 cells cannot survive in a
novel microenvironment (Fig. 5a and b). U-2 OS cells
have similar migration and survival capabilities to SJSA-1
cells when exposed to HULEC-5a CM (Figs. 1a, 5a and b).
However, U-2 OS cells rarely invade through the base-
ment membrane of distant tissue compared to SJSA-1
cells (Fig. 3b). It is well-accepted that cancer metastasis in-
volves several critical stages, including tumor invasion
through the local basement membrane, tumor cell survival
within the bloodstream and the initial survival of tumor
cells in the distant tumor stromal environment [20, 21].
SJSA-1 has dramatically higher invasion (Fig. 3b), migra-
tion (Fig. 1a and b), survival and proliferation potential in
lung cell co-culture (Fig. 5a and b). This reflects the high
metastatic potential of SJSA-1 in animal models.
An interesting finding in our study was the different
invasion and migration potential of OS cells following
lung cell co-culture. SJSA-1 had a higher invasiveness
Fig. 5 Migrated Osteosarcoma cells proliferation and survival increased in the HULEC-5a CM. a SaOS2, SJSA-1 and U2OS cells were induced to migrate
to HULEC-5a or MRC5 CM for 48 h, followed by culturing the migrated OS cells in regular culture medium for another 10 days. OS cells were fixed and
visualized by Giemsa staining. OS cell migration in regular medium is used as control. b Quantitative assays for Giemsa staining positive colony of the
OS cell in Fig. 5a. c BrdU staining of the SaOS2 and SJSA-1 cells migrating to HULEC-5a and MRC5 CM. Brown color represents the positive staining
Fig. 4 Osteosarcoma cell ALP expression increased in the co-culture of HULEC-5a cell. a SaOS2, SJSA-1 and U2OS cells were co-cultured with HULEC-
5a cells for 24, 48 and 72 h, followed by ALP staining assay. Single cell type culture of SaOS2, SJSA-1, U2OS and HULEC-5a were used as control. b
Quantitative densitometry assays for ALP staining in Fig. 4a. c High magnitude (100x) photos of ALP staining in Fig. 4a. d SaOS2, SJSA-1 and U2OS cells
were cultured in regular medium or HULEC-5a CM for 72 h, followed by ALP staining. e Quantitative densitometry assays for ALP staining in Fig. 4d. *
indicates the significant change of the ALP expression between SaOS2 and SaOS2 and HULEC-5a cell co-culture; # indicates the significant change of
the ALP expression between SJSA-1 and SJSA-1 and HULEC-5a cell co-culture. f) High magnitude (100x) photos of ALP staining in Fig. 4d
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Fig. 6 ALDH is involved in the increased migration of Osteosarcoma cells induced by HULEC-5a cell and CM. a ALDH mRNA level in SaOS2 and
SJSA-1 cells is increased in HULEC-5a CM compared with regular medium. b ALP expression in SaOS2 and SJSA-1 cell was suppressed by ALDH
inhibitor disulfiram in a dose-dependent manner, and HULEC-5a cell and CM rescue the ALP expression which is inhibited by disulfiram.
Quantitative densitometry assays for ALP staining in Fig. 6b. * indicates the significant difference of the ALP expression in SaOS2 and SJSA-1 cells
between single cell type culture of SaOS2/or SJSA-1 and the co-culture of SaOS2 and HULEC-5a cell treated with indicated dose of disulfiram. #
indicates the significant difference of the ALP expression between regular medium and HULEC-5a CM in SJSA-1 cells treated with indicated dose
of disulfiram. c BrdU staining for the SaOS2 and SJSA-1 cells treated with/without disulfiram. Brown color represents the positive staining
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compared to cells grown in HULEC-5a CM. Saos-2 and
U-2 OS have higher migration (Fig. 1a), but reduced
invasion potential compared to cells grown in HULEC-
5a CM (Fig. 3b). To migrate, the cell body must modify
its shape and stiffness to interact with the surrounding
tissue structures. Invasion requires adhesion, proteolysis
of extracellular matrix components and migration [22].
SJSA-1 cells become polarized and elongate when co-
cultured with HULEC-5a cells (Fig. 3a), an alteration that
may be a sentinel event of cell invasion. In contrast, U-2
OS cell morphology does not change when co-cultured
with HULEC-5a cells (Fig. 3a).Different lung cell types have different effects on OS cell
migration
Lung tissue is made up of multiple cell types, in-
cluding epithelial, endothelial and fibroblastic cells.
To characterize which cell type most effectively
attracts OS cells, we used CM from HULEC-5a, an
endothelial cell-line, and MRC-5, a fibroblastic cell-
line. Our data showed that HULEC-5a CM is a more
efficient attractant for OS cell migration compared
to MRC-5 CM (Figs. 1b, b, 2a and b).To further investigate if the lung cells themselves are
required to stimulate OS migration, we used CM contain-
ing doses of HULEC-5a cells or MRC-5 cells. Our data
demonstrate that 1x104 HULEC-5a or MRC-5 cells
further stimulate SJSA-1 cell migration compared to
HULEC-5a CM alone (Fig. 2a and b). This suggests that
some unknown properties of HULEC-5a and MRC-5 cells
also play important roles in the promotion of OS cell
migration. Interestingly, 5x104 HULEC-5a or MRC-5 cells
have the same effect as CM controls (Fig. 2a and b). The
reason why higher doses of HULEC-5a and MRC-5 cells
have a reduced effect on SJSA-1 cell migration remains
unclear. One possible explanation may be because too
many cells are competing for available nutrients in vitro
and producing cytotoxic byproducts.
ALP activity is a marker for OS lung metastasis
ALP has been previously demonstrated to be an indica-
tor of OS metastasis in multiple clinical studies [8–11].
High serum ALP levels are associated with the presence
of metastatic OS at the time of diagnosis, and poor
disease prognosis. Serum ALP level is a convenient and
effective biomarker of OS prognosis. In our study we
used ALP expression to monitor OS cell functional
changes in response to culture with HULEC-5a cells or
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cells was dramatically increased by HULEC-5a cell co-
culture. ALP expression was also noted at earlier time
points (Fig. 4a, b and c). In contrast, ALP expression was
not influenced by HULEC-5a CM (Fig. 4d, e and f). This
suggests that functional changes to OS cells requires
direct interaction with lung cells.
ALDH is involved in the process of OS cell migration to
lung cell
ALDH is a biomarker for cancer stem cells [23, 24].
Previous studies by our group have shown that ALDH
activity is greater in the highly metastatic K7M2 OS cell-
line than in non-metastatic K12 OS cells. We have also
correlated ALDH activity with clinical OS metastasis,
suggesting that ALDH may be a therapeutic target
specific to OS cells with high metastatic potential [25].
Subsequent studies found that Retinal, the precursor to
retinoic acid with known antitumor properties, targets
ALDH-positive cancer stem cells and alters the pheno-
type of highly metastatic OS cells [26]. When determin-
ing if ALDH was involved in OS cell functional changes
in response to the HULEC-5a microenvironment, we
found that HULEC-5a CM dramatically increases ALDH
expression in SJSA-1 and Saos-2 cells (Fig. 6a). In
contrast, in our loss-of-function experiments we treated
our experimental groups with doses of disulfiram, an
ALDH inhibitor. Our findings demonstrated that
HULEC-5a cells help SJSA-1 to resist disulfiram inhib-
ition and maintain their pro-metastatic function, indi-
cated by their preserved ALP activity (Fig. 6b). HULEC-
5a cells also supported SJSA-1 cell survival and prolifera-
tion in the presence of disulfiram (Fig. 6c). Our current
results are consistent with our previous findings [25, 26]
as well as those of other groups [23, 24].
While the findings of this study contribute to our
understanding of the mechanisms behind OS metastasis,
we recognize several limitations to this work. Our sam-
ple size throughout this study was often based on single
experiments, which highlights the preliminary nature of
our work. Our utilization of a murine fibroblast cell line
as a control was a decision made out of convenience, as
our group has significant experience and success with
this cell line. This will be altered in future studies. How-
ever, we believe that the relationships highlighted here
would persist regardless of cell line used.
Most importantly, our findings illustrate associative
relationships between OS cells and lung cells. While
these relationships may serve as the basis for new
theories, we have not established mechanisms (be-
yond ALDH activity) that explain them. While we
concede that our findings do not yield mechanistic
conclusions, we believe that the data presented here
(1) describe a new strategy by which the mechanismsbehind OS metastasis may be elucidated, and (2)
suggest that lung cells per se are active participants
in the metastatic process, either directly or indirectly
or both. Heretofore, this relationship has been
suggested by OS’s clinical behavior, but not demon-
strated. We hope that our findings will serve as the
foundation of future work that will identify causal
factors and mechanisms that will explain the
provocative phenomena we report here.
Conclusions
We have demonstrated that fibroblastic SJSA-1 OS cells
have a higher lung metastatic potential than epithelial
Saos-2 and U-2 OS cells. Lung endothelial HULEC-5a
cells are attractants for OS cell migration, proliferation
and survival. Further, the cancer stem cell marker ALDH
is involved in the interaction between lung and OS cells,
and ALP could be a valuable biomarker for monitoring
functional OS changes during the metastatic process.
These data will form the basis of future work that will
delve deeper into understanding the mechanisms by
which metastatic OS cells and the lung microenviron-
ment interact in the metastatic process.
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